N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine

C50H82N8O12Si2 — CID 162164036

IUPACN-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine
SMILESC1COCCN1.CC[C@H]1O[C@@H](n2ccc(NC(C)=O)nc2=O)[C@@H](OC)C1O[Si](C)(C)C(C)(C)C.CO[C@H]1C(O[Si](C)(C)C(C)(C)C)[C@@H](CN2CCOCC2)O[C@H]1n1ccc(NC(=O)c2ccccc2)nc1=O
InChIInChI=1S/C27H40N4O6Si.C19H33N3O5Si.C4H9NO/c1-27(2,3)38(5,6)37-22-20(18-30-14-16-35-17-15-30)36-25(23(22)34-4)31-13-12-21(29-26(31)33)28-24(32)19-10-8-7-9-11-19;1-9-13-15(27-28(7,8)19(3,4)5)16(25-6)17(26-13)22-11-10-14(20-12(2)23)21-18(22)24;1-3-6-4-2-5-1/h7-13,20,22-23,25H,14-18H2,1-6H3,(H,28,29,32,33);10-11,13,15-17H,9H2,1-8H3,(H,20,21,23,24);5H,1-4H2/t20-,22?,23+,25-;13-,15?,16+,17-;/m11./s1
InChIKeyZMWPNZXUXNZMCM-LOTAXKJSSA-N
MW1043.42 g/mol
LogP5.65
Rot. Bonds14

About N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine

N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine (PubChem CID 162164036) has the molecular formula C50H82N8O12Si2 and a molecular weight of 1043.42 g/mol. Its IUPAC name is N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine.

Molecular Properties

Compound NameN-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine
PubChem CID162164036
Molecular FormulaC50H82N8O12Si2
Molecular Weight1043.42 g/mol
Exact Mass1042.56
IUPAC NameN-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine
SMILESC1COCCN1.CC[C@H]1O[C@@H](n2ccc(NC(C)=O)nc2=O)[C@@H](OC)C1O[Si](C)(C)C(C)(C)C.CO[C@H]1C(O[Si](C)(C)C(C)(C)C)[C@@H](CN2CCOCC2)O[C@H]1n1ccc(NC(=O)c2ccccc2)nc1=O
InChIInChI=1S/C27H40N4O6Si.C19H33N3O5Si.C4H9NO/c1-27(2,3)38(5,6)37-22-20(18-30-14-16-35-17-15-30)36-25(23(22)34-4)31-13-12-21(29-26(31)33)28-24(32)19-10-8-7-9-11-19;1-9-13-15(27-28(7,8)19(3,4)5)16(25-6)17(26-13)22-11-10-14(20-12(2)23)21-18(22)24;1-3-6-4-2-5-1/h7-13,20,22-23,25H,14-18H2,1-6H3,(H,28,29,32,33);10-11,13,15-17H,9H2,1-8H3,(H,20,21,23,24);5H,1-4H2/t20-,22?,23+,25-;13-,15?,16+,17-;/m11./s1
InChIKeyZMWPNZXUXNZMCM-LOTAXKJSSA-N
XLogP5.65
TPSA217.09 Ų
H-Bond Donors3
H-Bond Acceptors18
Rotatable Bonds14
Heavy Atoms72
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001043.42
LogP ≤ 55.65
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[1-[(2R,3S,5R)-5-ethyl-3,4-dimethoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
CID 130467437
N-[1-[(2R,3R,4S,5S)-4-[tert-butyl(dimethyl)silyl]oxy-3-hydroxy-5-(sulfanylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 100937051
N-[1-[(2R,3R,4R,5R)-5-ethyl-4-hydroxy-3-(trideuteriomethoxy)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 165030936
N-[1-[(2R,3R,4R,5R)-5-ethyl-4-methyl-3-(trideuteriomethoxy)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 165030937
N-[1-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-[[(4-methoxyphenyl)-diphenylmethoxy]methyl]oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 11422742
[(2R,4S,5R)-5-(4-acetamido-2-oxopyrimidin-1-yl)-2-ethyl-4-methoxyoxolan-3-yl] 4-oxopentanoate
CID 159910265
4-[(2R,3R,4R,5R)-2-(4-benzamido-2-oxopyrimidin-1-yl)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl]oxy-4-oxobutanoic acid
CID 102082461
N-[1-[(2R,3R,4R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 170290421
N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-propoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 22874774
N-[1-[(2R,3S,5S)-5-(hydroxymethyl)-3-methoxy-4-methyloxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
CID 130474505
N-[1-[(2R,3R,4R,5R)-5-(1,1-dideuterioethyl)-4-hydroxy-3-(trideuteriomethoxy)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CID 165030932
1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione;1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
CID 157163438

Frequently Asked Questions

What is the IUPAC name of N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine?
The IUPAC name of N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine (CID 162164036) is N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine.
What is the SMILES notation for N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine?
The canonical SMILES for N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine is C1COCCN1.CC[C@H]1O[C@@H](n2ccc(NC(C)=O)nc2=O)[C@@H](OC)C1O[Si](C)(C)C(C)(C)C.CO[C@H]1C(O[Si](C)(C)C(C)(C)C)[C@@H](CN2CCOCC2)O[C@H]1n1ccc(NC(=O)c2ccccc2)nc1=O.
What is the InChIKey of N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine?
The InChIKey is ZMWPNZXUXNZMCM-LOTAXKJSSA-N. The full InChI is InChI=1S/C27H40N4O6Si.C19H33N3O5Si.C4H9NO/c1-27(2,3)38(5,6)37-22-20(18-30-14-16-35-17-15-30)36-25(23(22)34-4)31-13-12-21(29-26(31)33)28-24(32)19-10-8-7-9-11-19;1-9-13-15(27-28(7,8)19(3,4)5)16(25-6)17(26-13)22-11-10-14(20-12(2)23)21-18(22)24;1-3-6-4-2-5-1/h7-13,20,22-23,25H,14-18H2,1-6H3,(H,28,29,32,33);10-11,13,15-17H,9H2,1-8H3,(H,20,21,23,24);5H,1-4H2/t20-,22?,23+,25-;13-,15?,16+,17-;/m11./s1.
What are the key properties of N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine?
N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine has a molecular weight of 1043.42 g/mol, XLogP of 5.65, 14 rotatable bonds, 3 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-ethyl-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide;N-[1-[(2R,3S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-methoxy-5-(morpholin-4-ylmethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;morpholine is sourced from PubChem (CID 162164036), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).